APO Research
Talk to an analyst

APO RESEARCH · REPORT

Swine Erysipelas Vaccine

Compare research editions
View pricing & licenses

Selected research

Market Analysis & Forecast

Global Swine Erysipelas Vaccine Market Analysis and Forecast 2026-2032

2 January 2026199 pages

Choose your research edition.

Industry ResearchSwine Erysipelas Vaccine Industry Research Report 2026123 pages · $2,950 USDIndustry Growth & TrendsGlobal Swine Erysipelas Vaccine Industry Growth and Trends Forecast to 2032107 pages · $3,450 USDMarket StructureGlobal Swine Erysipelas Vaccine Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032193 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Swine Erysipelas Vaccine Market Outlook and Growth Opportunities 2026198 pages · $4,250 USDMarket Analysis & ForecastGlobal Swine Erysipelas Vaccine Market Analysis and Forecast 2026-2032199 pages · $4,950 USD

Market perspective

The global Swine Erysipelas Vaccine market is projected to grow from US$ million in 2026 to US$ million by 2032, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

The US & Canada market for Swine Erysipelas Vaccine is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Europe market for Swine Erysipelas Vaccine is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Read the full market overview

Asia-Pacific market for Swine Erysipelas Vaccine is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The China market for Swine Erysipelas Vaccine is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The major global manufacturers of Swine Erysipelas Vaccine include CAHIC, Zhejiang Shihua Nuo Beiwei Biotechnology Co., Ltd., Qilu Animal Health, Merck, Jiujiang Bomeilai Biological, Jilin Zhengye Biological, Hunan Zhong'an Biological Pharmaceutical Co., Ltd., Chengdu Tianbang Biology and Zoetis, etc. In 2025, the world's top three vendors accounted for approximately % of the revenue.

This report presents an overview of global market for Swine Erysipelas Vaccine, sales, revenue and price. Analyses of the global market trends, with historic market revenue or sales data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.

This report researches the key producers of Swine Erysipelas Vaccine, also provides the sales of main regions and countries. Of the upcoming market potential for Swine Erysipelas Vaccine, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Swine Erysipelas Vaccine sales, revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global Swine Erysipelas Vaccine market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, sales, revenue, and price, from 2021 to 2032. Evaluation and forecast the market size for Swine Erysipelas Vaccine sales, projected growth trends, production technology, application and end-user industry.

Swine Erysipelas Vaccine Segment by Company

CAHIC

Zhejiang Shihua Nuo Beiwei Biotechnology Co., Ltd.

Qilu Animal Health

Merck

Jiujiang Bomeilai Biological

Jilin Zhengye Biological

Hunan Zhong'an Biological Pharmaceutical Co., Ltd.

Chengdu Tianbang Biology

Zoetis

Boehringer Ingelheim

Swine Erysipelas Vaccine Segment by Type

Live

Inactivated

Swine Erysipelas Vaccine Segment by Application

Pharmacy

Online Sale

Others

Swine Erysipelas Vaccine Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Middle East & Africa

Turkey

Saudi Arabia

UAE

Study Objectives

1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Swine Erysipelas Vaccine market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Swine Erysipelas Vaccine and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Swine Erysipelas Vaccine.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by type and by application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Sales (consumption), revenue of Swine Erysipelas Vaccine in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.

Chapter 4: Detailed analysis of Swine Erysipelas Vaccine manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 5: Provides the analysis of various market segments by type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 6: Provides the analysis of various market segments by application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 7: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Swine Erysipelas Vaccine sales, revenue, price, gross margin, and recent development, etc.

Chapter 8: North America by type, by application and by country, sales, and revenue for each segment.

Chapter 9: Europe by type, by application and by country, sales, and revenue for each segment.

Chapter 10: China type, by application, sales, and revenue for each segment.

Chapter 11: Asia (excluding China) type, by application and by region, sales, and revenue for each segment.

Chapter 12: South America, Middle East and Africa by type, by application and by country, sales, and revenue for each segment.

Chapter 13: Analysis of industrial chain, sales channel, key raw materials, distributors and customers.

Chapter 14: The main concluding insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global Swine Erysipelas Vaccine Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Table 2. Live Major Manufacturers Table 3. Inactivated Major Manufacturers Table 4. Global Swine Erysipelas Vaccine Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Table 5. Pharmacy Major Manufacturers Table 6. Online Sale Major Manufacturers Table 7. Others Major Manufacturers Table 8. Swine Erysipelas Vaccine Industry Trends Table 9. Swine Erysipelas Vaccine Industry Drivers Table 10. Swine Erysipelas Vaccine Industry Opportunities and Challenges Table 11. Swine Erysipelas Vaccine Industry Restraints Table 12. Global Swine Erysipelas Vaccine Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 13. Global Swine Erysipelas Vaccine Revenue by Region (2021-2026) & (US$ Million) Table 14. Global Swine Erysipelas Vaccine Revenue by Region (2027-2032) & (US$ Million) Table 15. Global Swine Erysipelas Vaccine Revenue Market Share by Region (2021-2026) Table 16. Global Swine Erysipelas Vaccine Revenue Market Share by Region (2027-2032) Table 17. Global Swine Erysipelas Vaccine Sales Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (K Doses) Table 18. Global Swine Erysipelas Vaccine Sales by Region (2021-2026) & (K Doses) Table 19. Global Swine Erysipelas Vaccine Sales by Region (2027-2032) & (K Doses) Table 20. Global Swine Erysipelas Vaccine Sales Market Share by Region (2021-2026) Table 21. Global Swine Erysipelas Vaccine Sales Market Share by Region (2027-2032) Table 22. Global Swine Erysipelas Vaccine Revenue by Manufacturers (US$ Million) & (2021-2026) Table 23. Global Swine Erysipelas Vaccine Revenue Market Share by Manufacturers (2021-2026) Table 24. Global Swine Erysipelas Vaccine Sales by Manufacturers (US$ Million) & (2021-2026) Table 25. Global Swine Erysipelas Vaccine Sales Market Share by Manufacturers (2021-2026) Table 26. Global Swine Erysipelas Vaccine Sales Price (US$/Dose) of Manufacturers (2021-2026) Table 27. Global Swine Erysipelas Vaccine Key Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 28. Global Swine Erysipelas Vaccine Key Manufacturers Manufacturing Sites & Headquarters Table 29. Global Swine Erysipelas Vaccine Manufacturers, Product Type & Application Table 30. Global Swine Erysipelas Vaccine Manufacturers' Establishment Date Table 31. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 32. Global Swine Erysipelas Vaccine by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 33. Global Swine Erysipelas Vaccine Revenue by Type 2021 VS 2025 VS 2032 (US$ Million) Table 34. Global Swine Erysipelas Vaccine Revenue by Type (2021-2026) & (US$ Million) Table 35. Global Swine Erysipelas Vaccine Revenue by Type (2027-2032) & (US$ Million) Table 36. Global Swine Erysipelas Vaccine Revenue Market Share by Type (2021-2026) Table 37. Global Swine Erysipelas Vaccine Revenue Market Share by Type (2027-2032) Table 38. Global Swine Erysipelas Vaccine Sales by Type 2021 VS 2025 VS 2032 (K Doses) Table 39. Global Swine Erysipelas Vaccine Sales by Type (2021-2026) & (K Doses) Table 40. Global Swine Erysipelas Vaccine Sales by Type (2027-2032) & (K Doses) Table 41. Global Swine Erysipelas Vaccine Sales Market Share by Type (2021-2026) Table 42. Global Swine Erysipelas Vaccine Sales Market Share by Type (2027-2032) Table 43. Global Swine Erysipelas Vaccine Price by Type (2021-2026) & (US$/Dose) Table 44. Global Swine Erysipelas Vaccine Price by Type (2027-2032) & (US$/Dose) Table 45. Global Swine Erysipelas Vaccine Revenue by Application 2021 VS 2025 VS 2032 (US$ Million) Table 46. Global Swine Erysipelas Vaccine Revenue by Application (2021-2026) & (US$ Million) Table 47. Global Swine Erysipelas Vaccine Revenue by Application (2027-2032) & (US$ Million) Table 48. Global Swine Erysipelas Vaccine Revenue Market Share by Application (2021-2026) Table 49. Global Swine Erysipelas Vaccine Revenue Market Share by Application (2027-2032) Table 50. Global Swine Erysipelas Vaccine Sales by Application 2021 VS 2025 VS 2032 (K Doses) Table 51. Global Swine Erysipelas Vaccine Sales by Application (2021-2026) & (K Doses) Table 52. Global Swine Erysipelas Vaccine Sales by Application (2027-2032) & (K Doses) Table 53. Global Swine Erysipelas Vaccine Sales Market Share by Application (2021-2026) Table 54. Global Swine Erysipelas Vaccine Sales Market Share by Application (2027-2032) Table 55. Global Swine Erysipelas Vaccine Price by Application (2021-2026) & (US$/Dose) Table 56. Global Swine Erysipelas Vaccine Price by Application (2027-2032) & (US$/Dose) Table 57. CAHIC Company Information Table 58. CAHIC Business Overview Table 59. CAHIC Swine Erysipelas Vaccine Sales (K Doses), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2021-2026) Table 60. CAHIC Swine Erysipelas Vaccine Product Portfolio Table 61. CAHIC Recent Development Table 62. Zhejiang Shihua Nuo Beiwei Biotechnology Co., Ltd. Company Information Table 63. Zhejiang Shihua Nuo Beiwei Biotechnology Co., Ltd. Business Overview Table 64. Zhejiang Shihua Nuo Beiwei Biotechnology Co., Ltd. Swine Erysipelas Vaccine Sales (K Doses), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2021-2026) Table 65. Zhejiang Shihua Nuo Beiwei Biotechnology Co., Ltd. Swine Erysipelas Vaccine Product Portfolio Table 66. Zhejiang Shihua Nuo Beiwei Biotechnology Co., Ltd. Recent Development Table 67. Qilu Animal Health Company Information Table 68. Qilu Animal Health Business Overview Table 69. Qilu Animal Health Swine Erysipelas Vaccine Sales (K Doses), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2021-2026) Table 70. Qilu Animal Health Swine Erysipelas Vaccine Product Portfolio Table 71. Qilu Animal Health Recent Development Table 72. Merck Company Information Table 73. Merck Business Overview Table 74. Merck Swine Erysipelas Vaccine Sales (K Doses), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2021-2026) Table 75. Merck Swine Erysipelas Vaccine Product Portfolio Table 76. Merck Recent Development Table 77. Jiujiang Bomeilai Biological Company Information Table 78. Jiujiang Bomeilai Biological Business Overview Table 79. Jiujiang Bomeilai Biological Swine Erysipelas Vaccine Sales (K Doses), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2021-2026) Table 80. Jiujiang Bomeilai Biological Swine Erysipelas Vaccine Product Portfolio Table 81. Jiujiang Bomeilai Biological Recent Development Table 82. Jilin Zhengye Biological Company Information Table 83. Jilin Zhengye Biological Business Overview Table 84. Jilin Zhengye Biological Swine Erysipelas Vaccine Sales (K Doses), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2021-2026) Table 85. Jilin Zhengye Biological Swine Erysipelas Vaccine Product Portfolio Table 86. Jilin Zhengye Biological Recent Development Table 87. Hunan Zhong'an Biological Pharmaceutical Co., Ltd. Company Information Table 88. Hunan Zhong'an Biological Pharmaceutical Co., Ltd. Business Overview Table 89. Hunan Zhong'an Biological Pharmaceutical Co., Ltd. Swine Erysipelas Vaccine Sales (K Doses), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2021-2026) Table 90. Hunan Zhong'an Biological Pharmaceutical Co., Ltd. Swine Erysipelas Vaccine Product Portfolio Table 91. Hunan Zhong'an Biological Pharmaceutical Co., Ltd. Recent Development Table 92. Chengdu Tianbang Biology Company Information Table 93. Chengdu Tianbang Biology Business Overview Table 94. Chengdu Tianbang Biology Swine Erysipelas Vaccine Sales (K Doses), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2021-2026) Table 95. Chengdu Tianbang Biology Swine Erysipelas Vaccine Product Portfolio Table 96. Chengdu Tianbang Biology Recent Development Table 97. Zoetis Company Information Table 98. Zoetis Business Overview Table 99. Zoetis Swine Erysipelas Vaccine Sales (K Doses), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2021-2026) Table 100. Zoetis Swine Erysipelas Vaccine Product Portfolio Table 101. Zoetis Recent Development Table 102. Boehringer Ingelheim Company Information Table 103. Boehringer Ingelheim Business Overview Table 104. Boehringer Ingelheim Swine Erysipelas Vaccine Sales (K Doses), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2021-2026) Table 105. Boehringer Ingelheim Swine Erysipelas Vaccine Product Portfolio Table 106. Boehringer Ingelheim Recent Development Table 107. North America Swine Erysipelas Vaccine Revenue by Type (2021-2026) & (US$ Million) Table 108. North America Swine Erysipelas Vaccine Revenue by Type (2027-2032) & (US$ Million) Table 109. North America Swine Erysipelas Vaccine Sales by Type (2021-2026) & (K Doses) Table 110. North America Swine Erysipelas Vaccine Sales by Type (2027-2032) & (K Doses) Table 111. North America Swine Erysipelas Vaccine Sales Price by Type (2021-2026) & (US$/Dose) Table 112. North America Swine Erysipelas Vaccine Sales Price by Type (2027-2032) & (US$/Dose) Table 113. North America Swine Erysipelas Vaccine Revenue by Application (2021-2026) & (US$ Million) Table 114. North America Swine Erysipelas Vaccine Revenue by Application (2027-2032) & (US$ Million) Table 115. North America Swine Erysipelas Vaccine Sales by Application (2021-2026) & (K Doses) Table 116. North America Swine Erysipelas Vaccine Sales by Application (2027-2032) & (K Doses) Table 117. North America Swine Erysipelas Vaccine Sales Price by Application (2021-2026) & (US$/Dose) Table 118. North America Swine Erysipelas Vaccine Sales Price by Application (2027-2032) & (US$/Dose) Table 119. North America Swine Erysipelas Vaccine Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 120. North America Swine Erysipelas Vaccine Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 121. North America Swine Erysipelas Vaccine Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 122. North America Swine Erysipelas Vaccine Sales by Country (2021 VS 2025 VS 2032) & (K Doses) Table 123. North America Swine Erysipelas Vaccine Sales by Country (2021-2026) & (K Doses) Table 124. North America Swine Erysipelas Vaccine Sales by Country (2027-2032) & (K Doses) Table 125. North America Swine Erysipelas Vaccine Sales Price by Country (2021-2026) & (US$/Dose) Table 126. North America Swine Erysipelas Vaccine Sales Price by Country (2027-2032) & (US$/Dose) Table 127. United States Swine Erysipelas Vaccine Revenue (2021-2032) & (US$ Million) Table 128. Canada Swine Erysipelas Vaccine Revenue (2021-2032) & (US$ Million) Table 129. Europe Swine Erysipelas Vaccine Revenue by Type (2021-2026) & (US$ Million) Table 130. Europe Swine Erysipelas Vaccine Revenue by Type (2027-2032) & (US$ Million) Table 131. Europe Swine Erysipelas Vaccine Sales by Type (2021-2026) & (K Doses) Table 132. Europe Swine Erysipelas Vaccine Sales by Type (2027-2032) & (K Doses) Table 133. Europe Swine Erysipelas Vaccine Sales Price by Type (2021-2026) & (US$/Dose) Table 134. Europe Swine Erysipelas Vaccine Sales Price by Type (2027-2032) & (US$/Dose) Table 135. Europe Swine Erysipelas Vaccine Revenue by Application (2021-2026) & (US$ Million) Table 136. Europe Swine Erysipelas Vaccine Revenue by Application (2027-2032) & (US$ Million) Table 137. Europe Swine Erysipelas Vaccine Sales by Application (2021-2026) & (K Doses) Table 138. Europe Swine Erysipelas Vaccine Sales by Application (2027-2032) & (K Doses) Table 139. Europe Swine Erysipelas Vaccine Sales Price by Application (2021-2026) & (US$/Dose) Table 140. Europe Swine Erysipelas Vaccine Sales Price by Application (2027-2032) & (US$/Dose) Table 141. Europe Swine Erysipelas Vaccine Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 142. Europe Swine Erysipelas Vaccine Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 143. Europe Swine Erysipelas Vaccine Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 144. Europe Swine Erysipelas Vaccine Sales by Country (2021 VS 2025 VS 2032) & (K Doses) Table 145. Europe Swine Erysipelas Vaccine Sales by Country (2021-2026) & (K Doses) Table 146. Europe Swine Erysipelas Vaccine Sales by Country (2027-2032) & (K Doses) Table 147. Europe Swine Erysipelas Vaccine Sales Price by Country (2021-2026) & (US$/Dose) Table 148. Europe Swine Erysipelas Vaccine Sales Price by Country (2027-2032) & (US$/Dose) Table 149. Germany Swine Erysipelas Vaccine Revenue (2021-2032) & (US$ Million) Table 150. France Swine Erysipelas Vaccine Revenue (2021-2032) & (US$ Million) Table 151. U.K. Swine Erysipelas Vaccine Revenue (2021-2032) & (US$ Million) Table 152. Italy Swine Erysipelas Vaccine Revenue (2021-2032) & (US$ Million) Table 153. Netherlands Swine Erysipelas Vaccine Revenue (2021-2032) & (US$ Million) Table 154. China Swine Erysipelas Vaccine Revenue by Type (2021-2026) & (US$ Million) Table 155. China Swine Erysipelas Vaccine Revenue by Type (2027-2032) & (US$ Million) Table 156. China Swine Erysipelas Vaccine Sales by Type (2021-2026) & (K Doses) Table 157. China Swine Erysipelas Vaccine Sales by Type (2027-2032) & (K Doses) Table 158. China Swine Erysipelas Vaccine Sales Price by Type (2021-2026) & (US$/Dose) Table 159. China Swine Erysipelas Vaccine Sales Price by Type (2027-2032) & (US$/Dose) Table 160. China Swine Erysipelas Vaccine Revenue by Application (2021-2026) & (US$ Million) Table 161. China Swine Erysipelas Vaccine Revenue by Application (2027-2032) & (US$ Million) Table 162. China Swine Erysipelas Vaccine Sales by Application (2021-2026) & (K Doses) Table 163. China Swine Erysipelas Vaccine Sales by Application (2027-2032) & (K Doses) Table 164. China Swine Erysipelas Vaccine Sales Price by Application (2021-2026) & (US$/Dose) Table 165. China Swine Erysipelas Vaccine Sales Price by Application (2027-2032) & (US$/Dose) Table 166. Asia Swine Erysipelas Vaccine Revenue by Type (2021-2026) & (US$ Million) Table 167. Asia Swine Erysipelas Vaccine Revenue by Type (2027-2032) & (US$ Million) Table 168. Asia Swine Erysipelas Vaccine Sales by Type (2021-2026) & (K Doses) Table 169. Asia Swine Erysipelas Vaccine Sales by Type (2027-2032) & (K Doses) Table 170. Asia Swine Erysipelas Vaccine Sales Price by Type (2021-2026) & (US$/Dose) Table 171. Asia Swine Erysipelas Vaccine Sales Price by Type (2027-2032) & (US$/Dose) Table 172. Asia Swine Erysipelas Vaccine Revenue by Application (2021-2026) & (US$ Million) Table 173. Asia Swine Erysipelas Vaccine Revenue by Application (2027-2032) & (US$ Million) Table 174. Asia Swine Erysipelas Vaccine Sales by Application (2021-2026) & (K Doses) Table 175. Asia Swine Erysipelas Vaccine Sales by Application (2027-2032) & (K Doses) Table 176. Asia Swine Erysipelas Vaccine Sales Price by Application (2021-2026) & (US$/Dose) Table 177. Asia Swine Erysipelas Vaccine Sales Price by Application (2027-2032) & (US$/Dose) Table 178. Asia Swine Erysipelas Vaccine Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 179. Asia Swine Erysipelas Vaccine Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 180. Asia Swine Erysipelas Vaccine Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 181. Asia Swine Erysipelas Vaccine Sales by Country (2021 VS 2025 VS 2032) & (K Doses) Table 182. Asia Swine Erysipelas Vaccine Sales by Country (2021-2026) & (K Doses) Table 183. Asia Swine Erysipelas Vaccine Sales by Country (2027-2032) & (K Doses) Table 184. Asia Swine Erysipelas Vaccine Sales Price by Country (2021-2026) & (US$/Dose) Table 185. Asia Swine Erysipelas Vaccine Sales Price by Country (2027-2032) & (US$/Dose) Table 186. Japan Swine Erysipelas Vaccine Revenue (2021-2032) & (US$ Million) Table 187. South Korea Swine Erysipelas Vaccine Revenue (2021-2032) & (US$ Million) Table 188. India Swine Erysipelas Vaccine Revenue (2021-2032) & (US$ Million) Table 189. Australia Swine Erysipelas Vaccine Revenue (2021-2032) & (US$ Million) Table 190. China Taiwan Swine Erysipelas Vaccine Revenue (2021-2032) & (US$ Million) Table 191. Southeast Asia Swine Erysipelas Vaccine Revenue (2021-2032) & (US$ Million) Table 192. SAMEA Swine Erysipelas Vaccine Revenue by Type (2021-2026) & (US$ Million) Table 193. SAMEA Swine Erysipelas Vaccine Revenue by Type (2027-2032) & (US$ Million) Table 194. SAMEA Swine Erysipelas Vaccine Sales by Type (2021-2026) & (K Doses) Table 195. SAMEA Swine Erysipelas Vaccine Sales by Type (2027-2032) & (K Doses) Table 196. SAMEA Swine Erysipelas Vaccine Sales Price by Type (2021-2026) & (US$/Dose) Table 197. SAMEA Swine Erysipelas Vaccine Sales Price by Type (2027-2032) & (US$/Dose) Table 198. SAMEA Swine Erysipelas Vaccine Revenue by Application (2021-2026) & (US$ Million) Table 199. SAMEA Swine Erysipelas Vaccine Revenue by Application (2027-2032) & (US$ Million) Table 200. SAMEA Swine Erysipelas Vaccine Sales by Application (2021-2026) & (K Doses) Table 201. SAMEA Swine Erysipelas Vaccine Sales by Application (2027-2032) & (K Doses) Table 202. SAMEA Swine Erysipelas Vaccine Sales Price by Application (2021-2026) & (US$/Dose) Table 203. SAMEA Swine Erysipelas Vaccine Sales Price by Application (2027-2032) & (US$/Dose) Table 204. SAMEA Swine Erysipelas Vaccine Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 205. SAMEA Swine Erysipelas Vaccine Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 206. SAMEA Swine Erysipelas Vaccine Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 207. SAMEA Swine Erysipelas Vaccine Sales by Country (2021 VS 2025 VS 2032) & (K Doses) Table 208. SAMEA Swine Erysipelas Vaccine Sales by Country (2021-2026) & (K Doses) Table 209. SAMEA Swine Erysipelas Vaccine Sales by Country (2027-2032) & (K Doses) Table 210. SAMEA Swine Erysipelas Vaccine Sales Price by Country (2021-2026) & (US$/Dose) Table 211. SAMEA Swine Erysipelas Vaccine Sales Price by Country (2027-2032) & (US$/Dose) Table 212. Brazil Swine Erysipelas Vaccine Revenue (2021-2032) & (US$ Million) Table 213. Argentina Swine Erysipelas Vaccine Revenue (2021-2032) & (US$ Million) Table 214. Chile Swine Erysipelas Vaccine Revenue (2021-2032) & (US$ Million) Table 215. Colombia Swine Erysipelas Vaccine Revenue (2021-2032) & (US$ Million) Table 216. Peru Swine Erysipelas Vaccine Revenue (2021-2032) & (US$ Million) Table 217. Saudi Arabia Swine Erysipelas Vaccine Revenue (2021-2032) & (US$ Million) Table 218. Israel Swine Erysipelas Vaccine Revenue (2021-2032) & (US$ Million) Table 219. UAE Swine Erysipelas Vaccine Revenue (2021-2032) & (US$ Million) Table 220. Turkey Swine Erysipelas Vaccine Revenue (2021-2032) & (US$ Million) Table 221. Iran Swine Erysipelas Vaccine Revenue (2021-2032) & (US$ Million) Table 222. Egypt Swine Erysipelas Vaccine Revenue (2021-2032) & (US$ Million) Table 223. Key Raw Materials Table 224. Raw Materials Key Suppliers Table 225. Swine Erysipelas Vaccine Distributors List Table 226. Swine Erysipelas Vaccine Customers List Table 227. Research Programs/Design for This Report Table 228. Authors List of This Report Table 229. Secondary Sources Table 230. Primary Sources List of Figures Figure 1. Swine Erysipelas Vaccine Image Figure 2. Global Swine Erysipelas Vaccine Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Swine Erysipelas Vaccine Market Size Share 2021 VS 2025 VS 2032 Figure 4. Live Image Figure 5. Inactivated Image Figure 6. Global Swine Erysipelas Vaccine Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Figure 7. Global Swine Erysipelas Vaccine Market Size Share 2021 VS 2025 VS 2032 Figure 8. Pharmacy Image Figure 9. Online Sale Image Figure 10. Others Image Figure 11. Global Swine Erysipelas Vaccine Revenue (US$ Million), 2021 VS 2025 VS 2032 Figure 12. Global Swine Erysipelas Vaccine Revenue (2021-2032) & (US$ Million) Figure 13. Global Swine Erysipelas Vaccine Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 14. Global Swine Erysipelas Vaccine Revenue Market Share by Region: 2025 Versus 2032 Figure 15. Global Swine Erysipelas Vaccine Revenue Market Share by Region (2021-2032) Figure 16. Global Swine Erysipelas Vaccine Sales (2021-2032) & (K Doses) Figure 17. Global Swine Erysipelas Vaccine Sales by Region: 2021 VS 2025 VS 2032 (K Doses) Figure 18. Global Swine Erysipelas Vaccine Sales Market Share by Region (2021-2032) Figure 19. US & Canada & Mexico Swine Erysipelas Vaccine Sales YoY (2021-2032) & (K Doses) Figure 20. Europe Swine Erysipelas Vaccine Sales YoY (2021-2032) & (K Doses) Figure 21. China Swine Erysipelas Vaccine Sales YoY (2021-2032) & (K Doses) Figure 22. Asia (Excluding China) Swine Erysipelas Vaccine Sales YoY (2021-2032) & (K Doses) Figure 23. South America, Middle East and Africa Swine Erysipelas Vaccine Sales YoY (2021-2032) & (K Doses) Figure 24. Global Swine Erysipelas Vaccine Manufacturers Revenue Share Top 10 and Top 5 in 2025 Figure 25. Global Swine Erysipelas Vaccine Manufacturers Sales Share Top 10 and Top 5 in 2025 Figure 26. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 27. Global Swine Erysipelas Vaccine Revenue by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 28. Global Swine Erysipelas Vaccine Revenue Market Share by Type 2021 VS 2025 VS 2032 Figure 29. Global Swine Erysipelas Vaccine Revenue Market Share by Type (2021-2032) Figure 30. Global Swine Erysipelas Vaccine Sales by Type (2021 VS 2025 VS 2032) & (K Doses) Figure 31. Global Swine Erysipelas Vaccine Sales Market Share by Type 2021 VS 2025 VS 2032 Figure 32. Global Swine Erysipelas Vaccine Sales Market Share by Type (2021-2032) Figure 33. Global Swine Erysipelas Vaccine Revenue by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 34. Global Swine Erysipelas Vaccine Revenue Market Share by Application 2021 VS 2025 VS 2032 Figure 35. Global Swine Erysipelas Vaccine Revenue Market Share by Application (2021-2032) Figure 36. Global Swine Erysipelas Vaccine Sales by Application (2021 VS 2025 VS 2032) & (K Doses) Figure 37. Global Swine Erysipelas Vaccine Sales Market Share by Application 2021 VS 2025 VS 2032 Figure 38. Global Swine Erysipelas Vaccine Sales Market Share by Application (2021-2032) Figure 39. North America Swine Erysipelas Vaccine Revenue Share by Type (2021-2032) Figure 40. North America Swine Erysipelas Vaccine Sales Share by Type (2021-2032) Figure 41. North America Swine Erysipelas Vaccine Revenue Share by Application (2021-2032) Figure 42. North America Swine Erysipelas Vaccine Sales Share by Application (2021-2032) Figure 43. North America Swine Erysipelas Vaccine Revenue Share by Country (2021-2032) Figure 44. North America Swine Erysipelas Vaccine Sales Share by Country (2021-2032) Figure 45. Europe Swine Erysipelas Vaccine Revenue Share by Type (2021-2032) Figure 46. Europe Swine Erysipelas Vaccine Sales Share by Type (2021-2032) Figure 47. Europe Swine Erysipelas Vaccine Revenue Share by Application (2021-2032) Figure 48. Europe Swine Erysipelas Vaccine Sales Share by Application (2021-2032) Figure 49. Europe Swine Erysipelas Vaccine Revenue Share by Country (2021-2032) Figure 50. Europe Swine Erysipelas Vaccine Sales Share by Country (2021-2032) Figure 51. China Swine Erysipelas Vaccine Revenue Share by Type (2021-2032) Figure 52. China Swine Erysipelas Vaccine Sales Share by Type (2021-2032) Figure 53. China Swine Erysipelas Vaccine Revenue Share by Application (2021-2032) Figure 54. China Swine Erysipelas Vaccine Sales Share by Application (2021-2032) Figure 55. Asia Swine Erysipelas Vaccine Revenue Share by Type (2021-2032) Figure 56. Asia Swine Erysipelas Vaccine Sales Share by Type (2021-2032) Figure 57. Asia Swine Erysipelas Vaccine Revenue Share by Application (2021-2032) Figure 58. Asia Swine Erysipelas Vaccine Sales Share by Application (2021-2032) Figure 59. Asia Swine Erysipelas Vaccine Revenue Share by Country (2021-2032) Figure 60. Asia Swine Erysipelas Vaccine Sales Share by Country (2021-2032) Figure 61. SAMEA Swine Erysipelas Vaccine Revenue Share by Type (2021-2032) Figure 62. SAMEA Swine Erysipelas Vaccine Sales Share by Type (2021-2032) Figure 63. SAMEA Swine Erysipelas Vaccine Revenue Share by Application (2021-2032) Figure 64. SAMEA Swine Erysipelas Vaccine Sales Share by Application (2021-2032) Figure 65. SAMEA Swine Erysipelas Vaccine Revenue Share by Country (2021-2032) Figure 66. SAMEA Swine Erysipelas Vaccine Sales Share by Country (2021-2032) Figure 67. Swine Erysipelas Vaccine Value Chain Figure 68. Manufacturing Cost Structure Figure 69. Swine Erysipelas Vaccine Production Mode & Process Figure 70. Direct Comparison with Distribution Share Figure 71. Distributors Profiles Figure 72. Years Considered Figure 73. Research Process Figure 74. Key Executives Interviewed

Scope & coverage.

Types
  • Live
  • Inactivated
Applications
  • Pharmacy
  • Online Sale
  • Others
Companies covered
  • CAHIC
  • Zhejiang Shihua Nuo Beiwei Biotechnology Co., Ltd.
  • Qilu Animal Health
  • Merck
  • Jiujiang Bomeilai Biological
  • Jilin Zhengye Biological
  • Hunan Zhong'an Biological Pharmaceutical Co., Ltd.
  • Chengdu Tianbang Biology
  • Zoetis
  • Boehringer Ingelheim

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Swine Erysipelas Vaccine Market by Type
  3. 1.2.1 Global Swine Erysipelas Vaccine Market Size by Type, 2021 VS 2025 VS 2032
  4. 1.2.2 Live
  5. 1.2.3 Inactivated
  6. 1.3 Swine Erysipelas Vaccine Market by Application
  7. 1.3.1 Global Swine Erysipelas Vaccine Market Size by Application, 2021 VS 2025 VS 2032
  8. 1.3.2 Pharmacy
  9. 1.3.3 Online Sale
  10. 1.3.4 Others
  11. 1.4 Assumptions and Limitations
  12. 1.5 Study Goals and Objectives
2 Swine Erysipelas Vaccine Market Dynamics
  1. 2.1 Swine Erysipelas Vaccine Industry Trends
  2. 2.2 Swine Erysipelas Vaccine Industry Drivers
  3. 2.3 Swine Erysipelas Vaccine Industry Opportunities and Challenges
  4. 2.4 Swine Erysipelas Vaccine Industry Restraints
3 Global Market Growth Prospects
  1. 3.1 Global Swine Erysipelas Vaccine Revenue Estimates and Forecasts (2021-2032)
  2. 3.2 Global Swine Erysipelas Vaccine Revenue by Region
  3. 3.2.1 Global Swine Erysipelas Vaccine Revenue by Region: 2021 VS 2025 VS 2032
  4. 3.2.2 Global Swine Erysipelas Vaccine Revenue by Region (2021-2026)
  5. 3.2.3 Global Swine Erysipelas Vaccine Revenue by Region (2027-2032)
  6. 3.2.4 Global Swine Erysipelas Vaccine Revenue Market Share by Region (2021-2032)
  7. 3.3 Global Swine Erysipelas Vaccine Sales Estimates and Forecasts 2021-2032
  8. 3.4 Global Swine Erysipelas Vaccine Sales by Region
  9. 3.4.1 Global Swine Erysipelas Vaccine Sales by Region: 2021 VS 2025 VS 2032
  10. 3.4.2 Global Swine Erysipelas Vaccine Sales by Region (2021-2026)
  11. 3.4.3 Global Swine Erysipelas Vaccine Sales by Region (2027-2032)
  12. 3.4.4 Global Swine Erysipelas Vaccine Sales Market Share by Region (2021-2032)
  13. 3.5 US & Canada & Mexico
  14. 3.6 Europe
  15. 3.7 China
  16. 3.8 Asia (Excluding China)
  17. 3.9 South America, Middle East and Africa
4 Market Competitive Landscape by Manufacturers
  1. 4.1 Global Swine Erysipelas Vaccine Revenue by Manufacturers
  2. 4.1.1 Global Swine Erysipelas Vaccine Revenue by Manufacturers (2021-2026)
  3. 4.1.2 Global Swine Erysipelas Vaccine Revenue Market Share by Manufacturers (2021-2026)
  4. 4.1.3 Global Swine Erysipelas Vaccine Manufacturers Revenue Share Top 10 and Top 5 in 2025
  5. 4.2 Global Swine Erysipelas Vaccine Sales by Manufacturers
  6. 4.2.1 Global Swine Erysipelas Vaccine Sales by Manufacturers (2021-2026)
  7. 4.2.2 Global Swine Erysipelas Vaccine Sales Market Share by Manufacturers (2021-2026)
  8. 4.2.3 Global Swine Erysipelas Vaccine Manufacturers Sales Share Top 10 and Top 5 in 2025
  9. 4.3 Global Swine Erysipelas Vaccine Sales Price by Manufacturers (2021-2026)
  10. 4.4 Global Swine Erysipelas Vaccine Key Manufacturers Ranking, 2024 VS 2025 VS 2026
  11. 4.5 Global Swine Erysipelas Vaccine Key Manufacturers Manufacturing Sites & Headquarters
  12. 4.6 Global Swine Erysipelas Vaccine Manufacturers, Product Type & Application
  13. 4.7 Global Swine Erysipelas Vaccine Manufacturers' Establishment Date
  14. 4.8 Market Competitive Analysis
  15. 4.8.1 Global Swine Erysipelas Vaccine Market CR5 and HHI
  16. 4.8.2 2025 Swine Erysipelas Vaccine Tier 1, Tier 2, and Tier 3
5 Swine Erysipelas Vaccine Market by Type
  1. 5.1 Global Swine Erysipelas Vaccine Revenue by Type
  2. 5.1.1 Global Swine Erysipelas Vaccine Revenue by Type (2021 VS 2025 VS 2032)
  3. 5.1.2 Global Swine Erysipelas Vaccine Revenue by Type (2021-2032) & (US$ Million)
  4. 5.1.3 Global Swine Erysipelas Vaccine Revenue Market Share by Type (2021-2032)
  5. 5.2 Global Swine Erysipelas Vaccine Sales by Type
  6. 5.2.1 Global Swine Erysipelas Vaccine Sales by Type (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Swine Erysipelas Vaccine Sales by Type (2021-2032) & (K Doses)
  8. 5.2.3 Global Swine Erysipelas Vaccine Sales Market Share by Type (2021-2032)
  9. 5.3 Global Swine Erysipelas Vaccine Price by Type
6 Swine Erysipelas Vaccine Market by Application
  1. 6.1 Global Swine Erysipelas Vaccine Revenue by Application
  2. 6.1.1 Global Swine Erysipelas Vaccine Revenue by Application (2021 VS 2025 VS 2032)
  3. 6.1.2 Global Swine Erysipelas Vaccine Revenue by Application (2021-2032) & (US$ Million)
  4. 6.1.3 Global Swine Erysipelas Vaccine Revenue Market Share by Application (2021-2032)
  5. 6.2 Global Swine Erysipelas Vaccine Sales by Application
  6. 6.2.1 Global Swine Erysipelas Vaccine Sales by Application (2021 VS 2025 VS 2032)
  7. 6.2.2 Global Swine Erysipelas Vaccine Sales by Application (2021-2032) & (K Doses)
  8. 6.2.3 Global Swine Erysipelas Vaccine Sales Market Share by Application (2021-2032)
  9. 6.3 Global Swine Erysipelas Vaccine Price by Application
7 Company Profiles
  1. 7.1 CAHIC
  2. 7.1.1 CAHIC Company Information
  3. 7.1.2 CAHIC Business Overview
  4. 7.1.3 CAHIC Swine Erysipelas Vaccine Sales, Revenue, Price and Gross Margin (2021-2026)
  5. 7.1.4 CAHIC Swine Erysipelas Vaccine Product Portfolio
  6. 7.1.5 CAHIC Recent Developments
  7. 7.2 Zhejiang Shihua Nuo Beiwei Biotechnology Co., Ltd.
  8. 7.2.1 Zhejiang Shihua Nuo Beiwei Biotechnology Co., Ltd. Company Information
  9. 7.2.2 Zhejiang Shihua Nuo Beiwei Biotechnology Co., Ltd. Business Overview
  10. 7.2.3 Zhejiang Shihua Nuo Beiwei Biotechnology Co., Ltd. Swine Erysipelas Vaccine Sales, Revenue, Price and Gross Margin (2021-2026)
  11. 7.2.4 Zhejiang Shihua Nuo Beiwei Biotechnology Co., Ltd. Swine Erysipelas Vaccine Product Portfolio
  12. 7.2.5 Zhejiang Shihua Nuo Beiwei Biotechnology Co., Ltd. Recent Developments
  13. 7.3 Qilu Animal Health
  14. 7.3.1 Qilu Animal Health Company Information
  15. 7.3.2 Qilu Animal Health Business Overview
  16. 7.3.3 Qilu Animal Health Swine Erysipelas Vaccine Sales, Revenue, Price and Gross Margin (2021-2026)
  17. 7.3.4 Qilu Animal Health Swine Erysipelas Vaccine Product Portfolio
  18. 7.3.5 Qilu Animal Health Recent Developments
  19. 7.4 Merck
  20. 7.4.1 Merck Company Information
  21. 7.4.2 Merck Business Overview
  22. 7.4.3 Merck Swine Erysipelas Vaccine Sales, Revenue, Price and Gross Margin (2021-2026)
  23. 7.4.4 Merck Swine Erysipelas Vaccine Product Portfolio
  24. 7.4.5 Merck Recent Developments
  25. 7.5 Jiujiang Bomeilai Biological
  26. 7.5.1 Jiujiang Bomeilai Biological Company Information
  27. 7.5.2 Jiujiang Bomeilai Biological Business Overview
  28. 7.5.3 Jiujiang Bomeilai Biological Swine Erysipelas Vaccine Sales, Revenue, Price and Gross Margin (2021-2026)
  29. 7.5.4 Jiujiang Bomeilai Biological Swine Erysipelas Vaccine Product Portfolio
  30. 7.5.5 Jiujiang Bomeilai Biological Recent Developments
  31. 7.6 Jilin Zhengye Biological
  32. 7.6.1 Jilin Zhengye Biological Company Information
  33. 7.6.2 Jilin Zhengye Biological Business Overview
  34. 7.6.3 Jilin Zhengye Biological Swine Erysipelas Vaccine Sales, Revenue, Price and Gross Margin (2021-2026)
  35. 7.6.4 Jilin Zhengye Biological Swine Erysipelas Vaccine Product Portfolio
  36. 7.6.5 Jilin Zhengye Biological Recent Developments
  37. 7.7 Hunan Zhong'an Biological Pharmaceutical Co., Ltd.
  38. 7.7.1 Hunan Zhong'an Biological Pharmaceutical Co., Ltd. Company Information
  39. 7.7.2 Hunan Zhong'an Biological Pharmaceutical Co., Ltd. Business Overview
  40. 7.7.3 Hunan Zhong'an Biological Pharmaceutical Co., Ltd. Swine Erysipelas Vaccine Sales, Revenue, Price and Gross Margin (2021-2026)
  41. 7.7.4 Hunan Zhong'an Biological Pharmaceutical Co., Ltd. Swine Erysipelas Vaccine Product Portfolio
  42. 7.7.5 Hunan Zhong'an Biological Pharmaceutical Co., Ltd. Recent Developments
  43. 7.8 Chengdu Tianbang Biology
  44. 7.8.1 Chengdu Tianbang Biology Company Information
  45. 7.8.2 Chengdu Tianbang Biology Business Overview
  46. 7.8.3 Chengdu Tianbang Biology Swine Erysipelas Vaccine Sales, Revenue, Price and Gross Margin (2021-2026)
  47. 7.8.4 Chengdu Tianbang Biology Swine Erysipelas Vaccine Product Portfolio
  48. 7.8.5 Chengdu Tianbang Biology Recent Developments
  49. 7.9 Zoetis
  50. 7.9.1 Zoetis Company Information
  51. 7.9.2 Zoetis Business Overview
  52. 7.9.3 Zoetis Swine Erysipelas Vaccine Sales, Revenue, Price and Gross Margin (2021-2026)
  53. 7.9.4 Zoetis Swine Erysipelas Vaccine Product Portfolio
  54. 7.9.5 Zoetis Recent Developments
  55. 7.10 Boehringer Ingelheim
  56. 7.10.1 Boehringer Ingelheim Company Information
  57. 7.10.2 Boehringer Ingelheim Business Overview
  58. 7.10.3 Boehringer Ingelheim Swine Erysipelas Vaccine Sales, Revenue, Price and Gross Margin (2021-2026)
  59. 7.10.4 Boehringer Ingelheim Swine Erysipelas Vaccine Product Portfolio
  60. 7.10.5 Boehringer Ingelheim Recent Developments
8 North America
  1. 8.1 North America Swine Erysipelas Vaccine Market Size by Type
  2. 8.1.1 North America Swine Erysipelas Vaccine Revenue by Type (2021-2032)
  3. 8.1.2 North America Swine Erysipelas Vaccine Sales by Type (2021-2032)
  4. 8.1.3 North America Swine Erysipelas Vaccine Price by Type (2021-2032)
  5. 8.2 North America Swine Erysipelas Vaccine Market Size by Application
  6. 8.2.1 North America Swine Erysipelas Vaccine Revenue by Application (2021-2032)
  7. 8.2.2 North America Swine Erysipelas Vaccine Sales by Application (2021-2032)
  8. 8.2.3 North America Swine Erysipelas Vaccine Price by Application (2021-2032)
  9. 8.3 North America Swine Erysipelas Vaccine Market Size by Country
  10. 8.3.1 North America Swine Erysipelas Vaccine Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 8.3.2 North America Swine Erysipelas Vaccine Sales by Country (2021 VS 2025 VS 2032)
  12. 8.3.3 North America Swine Erysipelas Vaccine Price by Country (2021-2032)
  13. 8.3.4 United States
  14. 8.3.5 Canada
9 Europe
  1. 9.1 Europe Swine Erysipelas Vaccine Market Size by Type
  2. 9.1.1 Europe Swine Erysipelas Vaccine Revenue by Type (2021-2032)
  3. 9.1.2 Europe Swine Erysipelas Vaccine Sales by Type (2021-2032)
  4. 9.1.3 Europe Swine Erysipelas Vaccine Price by Type (2021-2032)
  5. 9.2 Europe Swine Erysipelas Vaccine Market Size by Application
  6. 9.2.1 Europe Swine Erysipelas Vaccine Revenue by Application (2021-2032)
  7. 9.2.2 Europe Swine Erysipelas Vaccine Sales by Application (2021-2032)
  8. 9.2.3 Europe Swine Erysipelas Vaccine Price by Application (2021-2032)
  9. 9.3 Europe Swine Erysipelas Vaccine Market Size by Country
  10. 9.3.1 Europe Swine Erysipelas Vaccine Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 9.3.2 Europe Swine Erysipelas Vaccine Sales by Country (2021 VS 2025 VS 2032)
  12. 9.3.3 Europe Swine Erysipelas Vaccine Price by Country (2021-2032)
  13. 9.3.4 Germany
  14. 9.3.5 France
  15. 9.3.6 U.K.
  16. 9.3.7 Italy
  17. 9.3.8 Netherlands
10 China
  1. 10.1 China Swine Erysipelas Vaccine Market Size by Type
  2. 10.1.1 China Swine Erysipelas Vaccine Revenue by Type (2021-2032)
  3. 10.1.2 China Swine Erysipelas Vaccine Sales by Type (2021-2032)
  4. 10.1.3 China Swine Erysipelas Vaccine Price by Type (2021-2032)
  5. 10.2 China Swine Erysipelas Vaccine Market Size by Application
  6. 10.2.1 China Swine Erysipelas Vaccine Revenue by Application (2021-2032)
  7. 10.2.2 China Swine Erysipelas Vaccine Sales by Application (2021-2032)
  8. 10.2.3 China Swine Erysipelas Vaccine Price by Application (2021-2032)
11 Asia (Excluding China)
  1. 11.1 Asia Swine Erysipelas Vaccine Market Size by Type
  2. 11.1.1 Asia Swine Erysipelas Vaccine Revenue by Type (2021-2032)
  3. 11.1.2 Asia Swine Erysipelas Vaccine Sales by Type (2021-2032)
  4. 11.1.3 Asia Swine Erysipelas Vaccine Price by Type (2021-2032)
  5. 11.2 Asia Swine Erysipelas Vaccine Market Size by Application
  6. 11.2.1 Asia Swine Erysipelas Vaccine Revenue by Application (2021-2032)
  7. 11.2.2 Asia Swine Erysipelas Vaccine Sales by Application (2021-2032)
  8. 11.2.3 Asia Swine Erysipelas Vaccine Price by Application (2021-2032)
  9. 11.3 Asia Swine Erysipelas Vaccine Market Size by Country
  10. 11.3.1 Asia Swine Erysipelas Vaccine Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 11.3.2 Asia Swine Erysipelas Vaccine Sales by Country (2021 VS 2025 VS 2032)
  12. 11.3.3 Asia Swine Erysipelas Vaccine Price by Country (2021-2032)
  13. 11.3.4 Japan
  14. 11.3.5 South Korea
  15. 11.3.6 India
  16. 11.3.7 Australia
  17. 11.3.8 Taiwan
  18. 11.3.9 Southeast Asia
12 South America, Middle East and Africa
  1. 12.1 SAMEA Swine Erysipelas Vaccine Market Size by Type
  2. 12.1.1 SAMEA Swine Erysipelas Vaccine Revenue by Type (2021-2032)
  3. 12.1.2 SAMEA Swine Erysipelas Vaccine Sales by Type (2021-2032)
  4. 12.1.3 SAMEA Swine Erysipelas Vaccine Price by Type (2021-2032)
  5. 12.2 SAMEA Swine Erysipelas Vaccine Market Size by Application
  6. 12.2.1 SAMEA Swine Erysipelas Vaccine Revenue by Application (2021-2032)
  7. 12.2.2 SAMEA Swine Erysipelas Vaccine Sales by Application (2021-2032)
  8. 12.2.3 SAMEA Swine Erysipelas Vaccine Price by Application (2021-2032)
  9. 12.3 SAMEA Swine Erysipelas Vaccine Market Size by Country
  10. 12.3.1 SAMEA Swine Erysipelas Vaccine Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 12.3.2 SAMEA Swine Erysipelas Vaccine Sales by Country (2021 VS 2025 VS 2032)
  12. 12.3.3 SAMEA Swine Erysipelas Vaccine Price by Country (2021-2032)
  13. 12.3.4 Brazil
  14. 12.3.5 Argentina
  15. 12.3.6 Chile
  16. 12.3.7 Colombia
  17. 12.3.8 Peru
  18. 12.3.9 Saudi Arabia
  19. 12.3.10 Israel
  20. 12.3.11 UAE
  21. 12.3.12 Turkey
  22. 12.3.13 Iran
  23. 12.3.14 Egypt
13 Value Chain and Sales Channels Analysis
  1. 13.1 Swine Erysipelas Vaccine Value Chain Analysis
  2. 13.1.1 Swine Erysipelas Vaccine Key Raw Materials
  3. 13.1.2 Raw Materials Key Suppliers
  4. 13.1.3 Manufacturing Cost Structure
  5. 13.1.4 Swine Erysipelas Vaccine Production Mode & Process
  6. 13.2 Swine Erysipelas Vaccine Sales Channels Analysis
  7. 13.2.1 Direct Comparison with Distribution Share
  8. 13.2.2 Swine Erysipelas Vaccine Distributors
  9. 13.2.3 Swine Erysipelas Vaccine Customers
14 Concluding Insights
    15 Appendix
    1. 15.1 Reasons for Doing This Study
    2. 15.2 Research Methodology
    3. 15.3 Research Process
    4. 15.4 Authors List of This Report
    5. 15.5 Data Source
    6. 15.5.1 Secondary Sources
    7. 15.5.2 Primary Sources
    8. 15.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst